ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0045409;negative regulation of interleukin-6 biosynthetic process;8.0;1.0;0.875;9.628524252492122;835.4451311618078;8.16763571524637;0.027961596688182013;0.7926932703116032;[GHSR, NLRP12]
GO:0060123;regulation of growth hormone secretion;9.0;0.8933024483968273;0.8428918493787028;9.510741216835738;106.7634718148897;7.212124270218933;0.003573277320757824;0.7650689957573628;[GHSR]
GO:0032691;negative regulation of interleukin-1 beta production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.92712208559752;6.781341354126479;0.002875903446815721;0.6977174774718518;[GHSR, NLRP3]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[SLA2, FGF5, IMPA2, GAB1, BTC, HBEGF, CD19, TRAT1]
GO:0008343;adult feeding behavior;3.0;1.0;0.6981203125901445;9.628524252492122;24.575257889458463;7.474488534686424;8.225117652639858E-4;0.5803660038532718;[GHSR]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[CDH5, C3AR1, GHSR, ANXA3, GAB1, CHI3L1, ENG, C5AR1, PTGS2, CXCR2, JUP, PLK2, LRG1]
GO:0003333;amino acid transmembrane transport;9.0;0.5756379274792419;0.68405958891991;8.302854513188667;195.84914281057607;5.500407508664414;0.006554894557084751;0.6775317209684948;[SLC38A11]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, PROK2, MAP4K1, MAP2K2, DUSP6, C5AR1, FPR1, CXCR4, IQGAP3, PKN1]
GO:0050796;regulation of insulin secretion;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;205.48125160941495;4.61801832846594;0.006877272570246766;0.6324062972578516;[GHSR, BLK, CNR1]
GO:0048240;sperm capacitation;4.0;1.0;0.75;9.628524252492122;67.15086498286243;6.558197802812269;0.0022474790191214893;0.5853865406232063;[SLC26A8, ROPN1L, SLC26A3]
GO:0001942;hair follicle development;4.0;1.0;0.75;9.628524252492122;22.36266381479647;6.166155715036245;7.48458232790436E-4;0.5653374900225189;[INHBA, CELSR1, LGR4]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[EHMT2, SLA2, MYB, MEF2C, ATF3, ELANE, PKIG, EZH2, PAWR, PAX5, AES, MMP12, FLNA, NR1H2, LGR4, GMNN, DACH1, TLE4, FOXO1, NACC2, WFS1, BCL6, CIITA, HHEX, RFC1, RBBP8, E2F7, KLF8, KLF5, ZNF608, EDNRB, RUNX2, PCBP3, EGR1, BCL11A, IFNA2, PTPRK, XPO1, ARID4A, BASP1, CCNE1, TGFB1, CBX4, HMGA1, NR4A2, MXD1, HMGB2, FBP1, MEIS2]
GO:0048246;macrophage chemotaxis;8.0;1.0;0.875;9.628524252492122;95.91852822164125;7.212124270218933;0.0032103068185073717;0.7438283705770736;[LGALS3, EDNRB, NUP85, AZU1]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPIB, AKT1, MEF2C, PADI2, ATF3, JAG1, JUP, MMP12, ATAD2, LGR4, BLM, FOXO1, CIITA, HHEX, E2F5, E2F7, POU2AF1, CCNH, EGR1, EGR2, EGR3, BRCA2, CCNE1, HMGA1, INHBA, TCF4, HMGB2, ARHGEF10L, NUP62, PSRC1, CREB5, CD4, RAN, EHF, MYB, NUP85, NFE2, PAX5, ENG, EPCAM, NR1H2, GTF2H1, CDH1, MAP2K2, MAFF, RFC1, CEBPE, KLF5, CHEK1, EBF1, RUNX2, BEX1, BCL11B, IFNA2, PRL, RHOG, CAMK4, ARID4A, NLRP3, TGFB1, NR4A2, NR4A1, SLC40A1, CKAP2, DNM2, MEIS2]
GO:2000110;negative regulation of macrophage apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;256.26138950429646;7.9853141584524145;0.008576838086431384;0.8046099625986299;[GHSR]
GO:0060474;positive regulation of flagellated sperm motility involved in capacitation;8.0;1.0;0.875;9.628524252492122;162.69194750477402;8.67846133901236;0.005445153069737985;0.8188169164668168;[CCR6]
GO:0071805;potassium ion transmembrane transport;9.0;0.8259837884571596;0.8092325194088689;9.456673995565463;120.6235085317852;4.695669262696007;0.004037160276449102;0.636377369645515;[KCNK5, KCNE3, KCNE4, KCNMB3, KCNJ15, KCNJ16]
GO:0030260;entry into host cell;6.0;0.7369933605727446;0.6916169928765168;8.68406264365127;26.98811751292015;5.212725436212633;9.032680054285688E-4;0.5896993338145817;[CDH1, ANPEP, CLEC5A, ITGB6, CR2, CR1, CXADR, GYPA, CXCR4, CD4]
GO:0007268;chemical synaptic transmission;7.0;0.7369933605727446;0.7194160455435727;8.663443356448536;23.173347188538074;3.922001705478042;7.755910757418987E-4;0.5514907148670789;[GRM5, CHRNB4, NPY1R, GJC1, HRH4, KCNMB3, GABRE, EGR3, HTR1E, PCDHB14, PNOC, PCDHB16, PCDHB4]
GO:0005513;detection of calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;27.95353479882516;7.212124270218933;9.355796531686605E-4;0.6919486831672181;[KCNMB3]
GO:0030815;negative regulation of cAMP metabolic process;10.0;0.8259837884571596;0.8282329060895002;9.526741558182179;1399.2283946151745;6.311337724880743;0.04683091514397047;0.7380031166185408;[P2RY13, GABBR1, EDNRB, HTR1E, HRH4, GNAI2]
GO:0030252;growth hormone secretion;9.0;1.0;0.896240625180289;9.628524252492122;103.34370176099773;7.8311634786251565;0.003458820694647294;0.7967266896635242;[GHSR]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[FGF5, GAB1, BTC, CHI3L1, HBEGF, ENG, CD19, TGFB1, TRAT1, PTK2, NOX4]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[MUC15, LYN, CLEC4D]
GO:0097067;cellular response to thyroid hormone stimulus;6.0;0.8933024483968273;0.7697715367885581;9.485423408851448;110.48347060425422;7.004484905440688;0.003697782332456301;0.6813299963962409;[GHSR, GAS2L1, CTSS]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[FGF5, MEF2C, MAP2K2, BTC, CSF2RB, IQGAP3, RASGRP4, TGFB1, PTK2, LAT, LRRK2, SPTAN1, MAP4K1, DUSP6, HBEGF]
GO:0006814;sodium ion transport;7.0;0.811012628672052;0.7564256795932265;9.310070521373587;34.16983994150393;4.629579150867016;0.001143633791982704;0.5876762583299873;[SLC8A1, SCN1A, SGK1, SLC22A4, SLC24A1, SLC24A4, SLC38A11]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[ITGAM, ITGB4, CTGF, ITGB6, CEACAM1, TLN1, PTK2, ZYX, LAT]
GO:0035815;positive regulation of renal sodium excretion;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;135.61946749691032;7.069023426578259;0.004539061527524972;0.7365101867784198;[EDNRB, GNAI2]
GO:0051781;positive regulation of cell division;5.0;0.6763753087927167;0.6284286662572787;8.438940185618286;42.28939918509474;5.358233019883872;0.0014153881327367882;0.5642612976810992;[CXCR5, FGF5, RACGAP1, NUP62, PDGFC, SVIL, TGFB1, CDC6, CIT, BTC]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, FPR1, HLA-DQA1, CDKN1A, LRRC4, FCER2, PTAFR, PTGS2, ALOX5, CSF3R, F13A1, IGHG1, IL13RA2, IFNA14, IFNA16, IFNA10, FOXO1, TNFRSF17, IFNA21, TNFRSF10C, BCL6, LCN2, HLA-DRA, CIITA, ITGAM, ACSL1, IL1R1, IL1R2, EGR1, IFNA5, IFNA4, IFNA7, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR6, CEACAM1, RHOU, CXCR5, CXCR4, CXCR1, CXCR2, IL18RAP, PRTN3, CSF2RB, TGFB1, CXCL1, CXCL2, MMP9, SAMHD1, CD4]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[CDKN1A, MYB, PDGFC, TGFB1, CDC6, BTC]
GO:2001226;negative regulation of chloride transport;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;90.21475614647593;8.67846133901236;0.0030194067002131896;0.8188169164668168;[GABRE]
GO:0010634;positive regulation of epithelial cell migration;8.0;0.7866048967936545;0.7683024483968273;9.383401794459138;242.52723865374625;4.901876304479318;0.00811716841739676;0.6256821821716325;[DOCK5, AKT1, CCR6, ANXA3, MMP9, PFN1, HBEGF, PTGS2, TGFB1, PLK2]
GO:0035810;positive regulation of urine volume;5.0;0.9326813400603323;0.7565816818910864;9.510741216835738;23.90496242438734;7.138016298065211;8.000775792748091E-4;0.6552794972956795;[BTC, EDNRB, GNAI2]
GO:0034163;regulation of toll-like receptor 9 signaling pathway;8.0;0.8653626801206646;0.8076813400603323;9.4949928598676;90.3094294018114;7.8311634786251565;0.0030225753288688696;0.7754860644832351;[FCRL3]
GO:0090327;negative regulation of locomotion involved in locomotory behavior;5.0;1.0;0.7902410118609202;9.628524252492122;71.01036791753914;9.083926447120524;0.002376653109017985;0.7547934328124444;[GHSR]
GO:1903672;positive regulation of sprouting angiogenesis;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;183.7504864323888;6.139487467954083;0.00614996341619065;0.6889736746265369;[GHSR, PLK2, PTGS2]
GO:0043134;regulation of hindgut contraction;8.0;0.8933024483968273;0.8216512241984136;9.427853557029971;36.05155056354762;9.083926447120524;0.0012066129530728933;0.839552420951524;[GHSR]
GO:1904646;cellular response to amyloid-beta;7.0;1.0;0.8509193652572005;9.628524252492122;273.93391051768003;6.518977089658987;0.009168321460513012;0.6843001567857983;[LRP1, FPR2, GRM5, FCGR2B]
GO:0042045;epithelial fluid transport;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;24.0554433753243;7.697632086000634;8.051140412786058E-4;0.6838982747154925;[EDNRB]
GO:0002587;negative regulation of antigen processing and presentation of peptide antigen via MHC class II;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;144.69507589410327;9.083926447120524;0.004842813973061743;0.8154717862087246;[HLA-DOA, HLA-DOB]
GO:1990314;cellular response to insulin-like growth factor stimulus;8.0;1.0;0.875;9.628524252492122;388.66587636398185;7.57984905034425;0.013008297105323164;0.7626338329336335;[GHSR, TGFB1]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[, AKT1, PROK2, FPR1, FPR2, IQGAP3, PRKAR2B, PDGFC, ELANE, LYN, CDC6, AZU1, NOX4, EZH2, CDKN1A, FCRL3, DUSP6, HBEGF, ENG, PTGS2, PKN1, CTGF, IFNA14, MAP2K2, IFNA16, IFNA10, IFNA21, LAT, LRRK2, FCGR2B, CCNH, TCL1A, EDNRB, ACSL1, EPHA3, EGR1, PTK2, CD24, IFNA5, IFNA4, IFNA7, IFNA2, CD3E, IFNA8, MAP4K1, BANK1, CXCR4, GNAI2, C5AR1, STAP1, TGFB1, INHBA, GH1, GRM5, MMP9, PSRC1, CHI3L1, LTF, CD4]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[EXO1, TLR8, FCGR2B, IL13RA2]
GO:2000145;regulation of cell motility;5.0;0.46812423412493653;0.5243031289233886;6.883086519318291;34.54403569627484;3.0677692874221707;0.001156157787140571;0.44712687588555144;[C3AR1, AKT1, MEF2C, CLDN7, PADI2, FPR2, PLA2G7, PDGFC, ELANE, LYN, JAG1, JUP, PLK2, NOX4, GPR18, ANXA3, TACR3, HBEGF, ENG, PTAFR, PTGS2, FLNA, JAM3, PKN1, SLC8A1, DACH1, TACSTD2, CORO1A, LRP1, LGALS3, IL1R1, ACTN4, BTC, PFN1, PTK2, BST1, PTPRR, PTPRK, CCR6, GAB1, CEACAM1, CEACAM6, SGK1, GNAI2, CXCR2, C5AR1, STAP1, TGFB1, DOCK5, MCTP1, TNFAIP6, LAMC2, CXCL1, CXCL2, ARAP3, MMP9, LAMA3]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[CSF3R, VPREB3, LGALS3, VPREB1, EDNRB, C3AR1, CD177, CXADR, PRTN3, S100A8, GYPA, C5AR1, FPR1, FPR2, CORO1A, NUP85, IGLV1-44, IGHA1, ELANE, LYN, TGFB1, AZU1, DEFA1, SELE, IGKV3-20, IGHM, ITGAM, CXCL1, CXCL2, TREM1, OLR1, FFAR2, CCR6, MMP9, CEACAM1, CEACAM6, CXCR5, CXCR4, IGKC, CXCR1, EPCAM, CXCR2, JAM2, JAM3, CD2, NLRP12]
GO:0001819;positive regulation of cytokine production;5.0;0.5089359064165209;0.5447089650691808;6.969264215559344;44.25546033084785;3.8109268885567773;0.001481190429944989;0.48513199016793795;[MYB, C3AR1, HHLA2, LY9, ELANE, EGR1, PRG2, AZU1, ORM1, CD3E, FFAR2, MMP12, TLR1, IGHD, TLR8, TLR7, TLR5, PTAFR, PTGS2, SULF2, NLRP12, CD83, CLEC5A, C5AR1, LY96, NLRP3, TGFB1, LRRK2, HMGB2, CD2, CD4]
GO:1903169;regulation of calcium ion transmembrane transport;8.0;0.6260725219892441;0.688036260994622;8.50005900067433;58.212370637888874;4.835431205071165;0.001948315657517866;0.6222841766978864;[SLC8A1, GEM, KCNE3, CORO1A, CD19, LYN, TGFB1, TSPAN13]
GO:0061098;positive regulation of protein tyrosine kinase activity;11.0;0.8436909121759173;0.8542744084176208;9.55953138100517;2154.6219316186807;5.8650506222523235;0.07211325701743153;0.7323679139043926;[GRM5, STAP1, CD24]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[REPS2, AKT1, TGFB1, GAB1, PTK2, BTC, KIF16B, HBEGF]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[PTPRK, CDH5, TGFB1, PTK2, ZYX]
GO:0051291;protein heterooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.113634533568402;0.00140677858073304;0.5846318204451575;[NUP62, CHRNB4, CLDN3, NUP54, NLGN1, JUP]
GO:0045840;positive regulation of mitotic nuclear division;8.0;0.7140352122741334;0.7320176061370667;9.138976027173417;276.06341799230654;5.75172193694532;0.009239594159256459;0.6691433273378073;[NUP62, SH2B1, RANBP1, TGFB1, BTC]
GO:0003376;sphingosine-1-phosphate signaling pathway;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;50.14720301582843;7.292166977892469;0.001678381755387122;0.6960420709600095;[GPR6]
GO:0043305;negative regulation of mast cell degranulation;11.0;0.9326813400603323;0.8987696223598284;9.607470843294289;1077.1478631716955;7.9853141584524145;0.03605116961021663;0.8407982897480031;[IL13RA2]
GO:0006885;regulation of pH;8.0;0.6997970393407541;0.724898519670377;8.992535485772125;35.59382883917596;5.266214121163619;0.0011912934188809815;0.6443144350603088;[LRRK2, EDNRB, SLC26A8, SLC26A3]
GO:0032922;circadian regulation of gene expression;6.0;1.0;0.8231203125901445;9.628524252492122;31.18462308171688;5.769740442447999;0.0010437212702063816;0.618185107137305;[PPP1CA, LGR4]
GO:0051969;regulation of transmission of nerve impulse;6.0;0.811012628672052;0.7286266269261705;9.34084218004034;42.49049401117059;7.004484905440688;0.0014221185955919531;0.6813299963962409;[GHSR, CHRNB4, TNR]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, LRRK2, SLC8A1, GRM5, EDNRB, CCR9, CCR6, LAT2, BTK, CXCR5, CXCR4, FPR2, CXCR1, CXCR2, AZU1, SELE, LAT]
GO:0051966;regulation of synaptic transmission, glutamatergic;7.0;0.811012628672052;0.7564256795932265;9.405380701177911;30.61939422688933;5.528578385631111;0.001024803569108247;0.6336511210035629;[MEF2C, NLGN1, LRRK2, PTGS2, GRM5, CNR1, TNR]
GO:0051963;regulation of synapse assembly;6.0;0.7090535922965819;0.6776471087384355;9.0306872517365;59.898395703774696;5.322726331426962;0.002004745399149018;0.5953247847114072;[NLGN1, GHSR, MEF2C, PTK2]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[EDNRB, C3AR1, AKT1, PROK2, TAS2R10, TRHR, ADCY9, FPR1, FPR2, AZU1, PNOC, GPR18, CD3E, CCR9, FFAR2, CCR6, RHOG, GPBAR1, TACR3, SORCS3, PTAFR, CXCR5, CXCR4, GNAI1, GNAI2, FGD4, CXCR1, CXCR2, FLNA, GABRE, P2RY13, GABBR1, SORT1, P2RY14, GPR6, LGR4, CELSR1, RGS1, GHSR, LHCGR, NPY1R, DGKZ, C5AR1, GPR84, HRH4, HTR1E, GNB2, TAS2R7, OR1G1, CXCL1, CXCL2, GRM5, GLP2R, LRP1, CNR1, TSHR, OR11A1]
GO:0042220;response to cocaine;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;106.24722930474235;6.343086423195323;0.0035559991485312878;0.647506047256038;[CNR1, TACR3, DNM2]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, C3AR1, RNASE3, RNASE2, PADI2, FPR1, FPR2, ELANE, JUP, AZU1, LYZ, TCN1, SIGLEC9, PYGL, OLR1, ANXA3, ARG1, SERPINB10, PTAFR, ALOX5, GSN, LRG1, SLCO4C1, SIGLEC5, HP, APEH, CLEC5A, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, HVCN1, GPR84, ATP8B4, DEFA4, DEFA1, LCN2, ITGAM, FCAR, FCGR3B, CR1, BPI, ACPP, FCGR2A, FOLR3, LGALS3, ANPEP, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, PRG2, NBEAL2, BST1, VNN1, ORM1, CTSS, CTSG, SPTAN1, CAMP, MME, RHOG, CEACAM1, CEACAM6, LILRA3, CXCR1, CXCR2, QPCT, CHRNB4, OSCAR, DOK3, PRTN3, C5AR1, MGAM, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, CHI3L1, LTF, CLEC12A, RETN, S100P, PTX3]
GO:0007188;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;7.0;0.7090535922965819;0.7054461614054914;8.712233520617966;27.67007993335845;4.535326612620827;9.260926739143067E-4;0.5828561791408859;[GRM5, RGS1, LHCGR, GLP2R, NPY1R, ADCY9, FPR1, FPR2, GPR84, GNAI1, GNAI2, CNR1, HRH4, FLNA, GABBR1, HTR1E, TSHR, LGR4]
GO:0007189;adenylate cyclase-activating G-protein coupled receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.249034630787218;56.871035456649615;5.192106149009898;0.0019034223761250782;0.6617651750982834;[GNAI2, LHCGR, TSHR, ADCY9, LGR4]
GO:0042104;positive regulation of activated T cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;649.8896198547563;6.599019797332524;0.021751220713853325;0.7527151911823093;[HHLA2, CD24, ICOSLG]
GO:0051971;positive regulation of transmission of nerve impulse;7.0;0.9326813400603323;0.8172600352873667;9.567899630675686;161.98963704071667;7.9853141584524145;0.005421647370544368;0.7592887026755414;[CHRNB4, TNR]
GO:0001755;neural crest cell migration;6.0;0.7980440201809971;0.722142322680643;9.089527751759436;22.57397290845719;5.825829909099042;7.555305579894227E-4;0.6210535250702663;[EDNRB]
GO:0071320;cellular response to cAMP;7.0;1.0;0.8509193652572005;9.628524252492122;327.37290077043656;5.825829909099042;0.01095687637230394;0.6488525777373224;[PTAFR, AQP9, SLC8A1, NOX4, SLC26A3]
GO:0014826;vein smooth muscle contraction;10.0;1.0;0.9152410118609203;9.628524252492122;72.04955416761116;8.390779266560578;0.002411433737600989;0.8443458537639685;[EDNRB]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[BRCA2, CTGF, GHSR, DUSP1, TACR3, PCNA, ABCB4, PTGS2, RBBP8, TGFB1, GH1, CD4, EZH2]
GO:0010107;potassium ion import;10.0;0.9326813400603323;0.8815816818910864;9.571365838652174;121.72212082045542;6.063501560976162;0.004073929841064025;0.7253287636709003;[KCNJ15, KCNJ16]
GO:0032354;response to follicle-stimulating hormone;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;26.60980005211952;6.943860283624253;8.906060604791816E-4;0.6782296504172152;[GHSR, POR, INHBA]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[CTGF, FGF5, VSTM1, MEF2C, IFNA14, IFNA16, BTC, IFNA10, PDGFC, IFNA21, TGFB1, JAG1, INHBA, GH1, PNOC, OGN, IFNA5, IFNA4, IFNA7, IFNA2, CXCL1, PRL, IFNA8, CXCL2, HBEGF, NLGN1, RETN, CMTM2, FCGR2B]
GO:1904155;DN2 thymocyte differentiation;8.0;1.0;0.875;9.628524252492122;68.09311559111913;9.777073627680469;0.0022790152990093482;0.875;[CCR6]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[ANPEP, CLEC5A, ITGB6, CR2, CR1, CXADR, GYPA]
GO:0019934;cGMP-mediated signaling;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;28.507808342730176;7.069023426578259;9.541306898693577E-4;0.7365101867784198;[EDNRB, PRKAR2B]
GO:0007271;synaptic transmission, cholinergic;8.0;1.0;0.875;9.628524252492122;25.73829654599903;6.409777797693995;8.61437622431563E-4;0.7027963346592216;[CHRNB4]
GO:1904156;DN3 thymocyte differentiation;8.0;1.0;0.875;9.628524252492122;68.09311559111913;9.777073627680469;0.0022790152990093482;0.875;[CCR6]
GO:0043568;positive regulation of insulin-like growth factor receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;186.95064880168647;7.212124270218933;0.006257069970731893;0.7197477358342742;[GH1, GHSR, CDH3]
GO:0099566;regulation of postsynaptic cytosolic calcium ion concentration;11.0;0.8933024483968273;0.8790801765280758;9.57973408832269;290.3013502407617;8.67846133901236;0.00971612493830514;0.8762458687964789;[GRM5]
GO:0072202;cell differentiation involved in metanephros development;5.0;0.7436939687323844;0.6620879962271125;8.647694999480395;23.631175140259693;7.069023426578259;7.909141652676152E-4;0.6517511986393402;[LGR4]
GO:0034765;regulation of ion transmembrane transport;6.0;0.45556283921517005;0.5509017321977295;6.676594601596523;33.03735142972539;3.697140432584879;0.0011057304206669666;0.512192246247148;[, SLC8A1, AKT1, SCN1A, MEF2C, CACNA2D3, ACTN4, GEM, KCNE3, KCNE4, HVCN1, CORO1A, CD19, LYN, TGFB1, KCNK5, CTSS, GRM5, MMP9, DNM2, NLGN1, PTAFR, FLNA, KCNJ15, KCNJ16, TSPAN13]
GO:0032100;positive regulation of appetite;9.0;1.0;0.896240625180289;9.628524252492122;112.0314975677904;8.390779266560578;0.003749593401792039;0.8253454670833372;[GHSR]
GO:0032228;regulation of synaptic transmission, GABAergic;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;30.61939422688933;6.311337724880743;0.001024803569108247;0.6736814700148209;[NLGN1, CNR1]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[, CYFIP1, SLA2, MYB, C3AR1, UBASH3A, MEF2C, CXADR, HHLA2, FPR1, FPR2, IGHA1, HLA-DQA1, ELANE, LYN, SIGLEC9, ARG1, FCRL3, PAWR, PAX5, MMP12, FCER2, TLR10, PTAFR, UNG, NR1H2, PKN1, CLC, LGR4, IGHG1, GRAP2, IL13RA2, CD177, CD180, MSH6, CLEC4D, MSH2, S100A8, BLK, LY96, IGLV1-44, BMX, BCL6, HLA-DRA, LAT, ITGAM, TREM1, FCGR3A, CR2, CR1, UNC93B1, NLRC4, FCGR2A, FCGR2B, LGALS3, ICOSLG, BTK, STXBP2, CD1B, CD79B, CD79A, CD19, SH2D1A, PTK2, CD24, CD200, IGHM, IFNA2, CD3G, CD3E, CTSS, FFAR2, CTSG, MUC15, LAT2, TLR1, CEACAM1, IGHD, TLR8, TLR7, TLR5, IGKC, MLH1, IL18RAP, OSCAR, CD300C, C5AR1, STAP1, NLRP3, TGFB1, IGKV3-20, HMGB2, LTF, SAMHD1, CNR1, TRAT1, CD4]
GO:0035176;social behavior;3.0;1.0;0.6981203125901445;9.628524252492122;22.58175877758554;5.8067817141283475;7.557911440223213E-4;0.49507939949363344;[NLGN4Y, NRXN3]
GO:0045759;negative regulation of action potential;5.0;0.7586651285174919;0.6695735761196662;9.089527751759436;33.79526974805598;7.8311634786251565;0.0011310972646992894;0.6907270763441554;[KCNE3, CNR1]
GO:0007043;cell-cell junction assembly;5.0;0.7508913569872202;0.6656866903545304;8.817594036275793;53.94372379865016;5.16195311083921;0.0018054478893412883;0.554223534004606;[GJC1, CDH5, CDH3, CDH1, JUP, LSR, ACTN4, CLDN3, CD9, TLN1]
GO:0007162;negative regulation of cell adhesion;5.0;0.5651597194614189;0.5728208715916296;7.400047131651798;38.26822196421712;4.255612709818223;0.001280802949978559;0.5078732437472537;[, LGALS3, CDH1, TNR, ACTN4, CLDN7, TACSTD2, TGFB1, JAG1, PTK2, BCL6, IFNA2, ARHGAP6, ARG1, PAWR, CEACAM1, EPCAM, JAM2, CD9, FCGR2B, SIPA1]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[, SLA2, C3AR1, AKT1, MEF2C, HHLA2, FPR1, FPR2, PDGFC, LYN, JAG1, VANGL1, SIGLEC9, LRRC4, PTAFR, PTGS2, FLNA, P2RY13, P2RY14, LGR4, NCF4, F13A1, CTGF, AP2M1, IFNA14, IFNA16, IFNA10, BLK, TACSTD2, LY96, CORO1A, FOXO1, TNFRSF17, IFNA21, TNFRSF10C, BMX, LCN2, HLA-DRA, CIITA, ITGAM, ITGB4, LRRK2, HHEX, FCGR3A, ITGB6, TSPAN13, FCGR2A, FCGR2B, BTC, BTK, EPHA3, CD19, TSPAN2, EGR1, PTK2, CD24, IGHM, PTPRR, TNFRSF13B, CD3G, PTPRK, CD3E, CCR9, CD37, CCR6, MUC15, GAB1, LAT2, IGHD, GNAI2, IGKC, SORT1, CELSR1, GEM, OSCAR, CCNE1, RASGRP4, INHBA, GH1, IGKV3-20, SIRPB1, GRM5, NUP62, MMP9, SAMHD1, CD2, CD4, CD7, CD9, CDA, CYFIP1, STMN1, IGHA1, HLA-DQA1, CDK14, CDKN1A, AES, FCER2, HBEGF, ENG, ALOX5, G0S2, SULF2, ZYX, CSF3R, FGF5, CDH5, IGHG1, CDH3, GRAP2, IL13RA2, TLE4, CLEC4D, IGLV1-44, BCL6, LAT, CR2, CR1, P2RX5, EDNRB, ICOSLG, ACSL1, IL1R1, IL1R2, RUNX2, TLN1, PFN1, CD79B, CD79A, IFNA5, IFNA4, IFNA7, IFNA2, PRL, IFNA8, FFAR2, GPBAR1, CEACAM1, RHOU, CXCR5, CXCR4, CXCR1, CXCR2, KRT19, IL18RAP, TSC2, KIF16B, PRTN3, C5AR1, CSF2RB, STAP1, TGFB1, NR4A2, CXCL1, CXCL2, BLNK, GLP2R, REPS2, TRAT1, TSHR]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[SLC8A1, EDNRB, C3AR1, PROK2, C5AR1, FPR1, FPR2, CD19, HRH4, ELANE, TGFB1, WFS1, CD24, GPR18, ATP2A3, GRM5, CCR9, CCR6, CD52, SLC24A1, SLC24A4, CXCR5, CXCR4, CXCR1, CXCR2, GPR6, P2RX5, CD4]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[HMGB2, CXCL1, CXCL2, EDNRB, CTSG, GHSR, MEF2C, ARG1, CD180, CEBPE, STAP1, NLRP3, NR1H2, DEFA4, DEFA1]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, SLA2, LGALS3, RNASE6, RNASE3, SLPI, BTK, LY9, IGHA1, LYN, SH2D1A, PTK2, VNN1, IFNA5, IFNA4, IGHM, IFNA7, IFNA2, IFNA8, CAMP, ARG1, TLR1, IGHD, TLR8, TLR10, TLR7, TLR5, LILRA5, IGKC, LGR4, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, CLEC4D, S100A8, IFNA10, BLK, LY96, CORO1A, NLRP3, IFNA21, TGFB1, DEFA4, DEFA1, BMX, LCN2, ITGAM, CRISP3, HMGB2, TREM1, SIRPB1, CR2, CR1, LTF, UNC93B1, HIST1H2BK, NLRC4, PTX3]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[, ELANE, BARD1, ST14, AZU1, OLR1, MMP12, FAM105A, ADAM28, APEH, IGHG1, RUVBL1, ADAM2, IGLV1-44, CLCA4, WFS1, DHCR24, ADAMTS20, RNF24, ANPEP, SKP2, CTSS, CTSG, MME, IGKC, RANBP1, PRTN3, TRHDE, NLRP3, TGFB1, IGKV3-20, MMP8, MMP9, LTF]
GO:0072679;thymocyte migration;8.0;0.8933024483968273;0.8216512241984136;9.533214072687796;31.84507234699532;9.083926447120524;0.0010658259127495017;0.839552420951524;[CCR6]
GO:0035725;sodium ion transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;113.92400819162063;5.014899692882714;0.0038129340292226534;0.6314622035107071;[SLC24A1, SLC24A4, SLC8A1, SCN1A]
GO:0071345;cellular response to cytokine stimulus;5.0;0.6729672293956388;0.6267246265587396;8.214830917184116;61.59823360834823;3.805811787890007;0.0020616374440603005;0.48487040368196277;[PID1, TCL1A, AKT1, BTK, PADI2, STXBP2, ST3GAL6, EGR1, MME, ARG1, CXCR4, GSN, NLRP12, ZYX, TLE4, KIF16B, CSF2RB, CORO1A, CHI3L1, MCM2, CD4, KLF5]
GO:0071467;cellular response to pH;5.0;0.811012628672052;0.6957473261969462;9.223059144383958;37.43295934218388;6.686031174322154;0.0012528474617066626;0.6321649570480018;[HVCN1]
GO:0042536;negative regulation of tumor necrosis factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;858.4851481575464;7.9853141584524145;0.0287327253223603;0.7833693374183408;[GHSR]
GO:0060084;synaptic transmission involved in micturition;9.0;1.0;0.896240625180289;9.628524252492122;25.73829654599903;8.67846133901236;8.61437622431563E-4;0.8400575416471059;[CHRNB4]
GO:0060405;regulation of penile erection;4.0;0.8933024483968273;0.6966512241984136;9.34084218004034;34.931128415581114;7.8311634786251565;0.0011691134320949222;0.6504860644832351;[EDNRB, CNR1]
GO:0060406;positive regulation of penile erection;5.0;1.0;0.7902410118609202;9.628524252492122;118.0711512965144;8.16763571524637;0.003951735176756968;0.7079342821725234;[EDNRB]
GO:0046697;decidualization;4.0;1.0;0.75;9.628524252492122;34.68251427445171;6.781341354126479;0.0011607925405295219;0.5967981122146513;[GHSR, PTGS2]
GO:0022008;neurogenesis;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.572381008289503;7.050676185779127E-4;0.5349718239061428;[CXCR4, CDH1, NUP133, BCL11B, BCL11A, CIT]
GO:0045923;positive regulation of fatty acid metabolic process;7.0;0.7140352122741334;0.7079369713942671;9.060540214886183;231.9593740122305;6.280566066213989;0.007763471498305934;0.6721078059595746;[GHSR, NR1H2, PTGS2]
GO:0007413;axonal fasciculation;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;31.514364772604104;6.7325511899570465;0.0010547574278521217;0.6952223462072524;[CNR1, NCAM2, EPHA3]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[SLC8A1, MYB, AKT1, ACTN4, CLDN3, ABCB4, EGR1, TGFB1, NR4A2, NOX4, CD24, CXCR4, PTGS2]
GO:0031999;negative regulation of fatty acid beta-oxidation;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;724.8195482541148;8.16763571524637;0.024259057984822387;0.8139338954918922;[CNR1, AKT1]
GO:0052695;cellular glucuronidation;9.0;0.8653626801206646;0.8289219652406215;9.446202695698167;85.04062765322598;6.8867018697843045;0.0028462332759574376;0.7484268790654467;[UGT2A3]
GO:0051001;negative regulation of nitric-oxide synthase activity;7.0;1.0;0.8509193652572005;9.628524252492122;123.18001952109483;7.8311634786251565;0.0041227243985507795;0.7514054297404357;[CNR1]
GO:0002638;negative regulation of immunoglobulin production;7.0;0.7980440201809971;0.7499413753476991;9.193206181234276;77.13462423321295;7.474488534686424;0.0025816264564307383;0.7331650565203278;[BCL6, FCRL3, FCGR2B, IL13RA2]
GO:2000510;positive regulation of dendritic cell chemotaxis;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;509.141903474748;7.697632086000634;0.01704052131133542;0.8088982747154926;[CCR6]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[CTSS, HLA-DOA, HLA-DOB, AP2M1, DNM2, HLA-DMA, RACGAP1, HLA-DQA1, HLA-DRA, FCGR2B]
GO:0015701;bicarbonate transport;7.0;1.0;0.8509193652572005;9.628524252492122;31.887457555831563;6.015873511986907;0.0010672445075450394;0.6585714164269392;[CA4, SLC26A8, SLC26A3]
GO:0050710;negative regulation of cytokine secretion;9.0;0.6954798709641801;0.743980560662379;9.089527751759436;549.9868642983072;5.734022359845919;0.01840756539202174;0.6894787953221185;[IFNA2, NLRP3, GHSR, IL1R2, NLRP12, BANK1, TLR8, FCGR2B, LGR4]
GO:0002092;positive regulation of receptor internalization;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;393.55365953464764;6.599019797332524;0.013171886809326083;0.7337148045016781;[SELE]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[TNFAIP6, CDH5, GHSR, IL1R2, NLRP3, ELANE, NLRP12, FCGR2B]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CYFIP1, CDH5, CDH3, CDH1, MEF2C, ACTN1, CLDN3, ST14, BCL11B, BCL6, NOX4, FLNA]
GO:0034220;ion transmembrane transport;5.0;0.44800904580126355;0.514245534761552;6.183841758890227;26.332710660334534;2.96803432163749;8.813321279004005E-4;0.4420264250971726;[AQP9, SCN1A, CACNA2D3, CLDN4, SLC22A4, GJC1, KCNMB3, CLDN17, SGK1, GABRE, STEAP4, DENND5B, SLC8A1, CHRNB4, KCNE3, KCNE4, HVCN1, SLC38A11, CLCA4, SLC26A8, SLC26A3, KCNK5, ATP2A3, SLC40A1, SLC24A1, SLC24A4, KCNJ15, KCNJ16, P2RX5]
GO:1902600;proton transmembrane transport;8.0;0.7586651285174919;0.754332564258746;9.117698628726131;95.86613314633948;4.835431205071165;0.0032085532024895276;0.6222841766978864;[HVCN1]
GO:1904349;positive regulation of small intestine smooth muscle contraction;10.0;1.0;0.9152410118609203;9.628524252492122;112.16807620771051;8.67846133901236;0.00375416456595737;0.8590579283277371;[GHSR]
GO:1904468;negative regulation of tumor necrosis factor secretion;10.0;1.0;0.9152410118609203;9.628524252492122;776.4370852710225;7.8311634786251565;0.02598665049601094;0.8157270763441555;[GHSR]
GO:0090190;positive regulation of branching involved in ureteric bud morphogenesis;8.0;1.0;0.875;9.628524252492122;298.04283299406984;6.832634648514029;0.009975225399176214;0.7244212536750128;[TGFB1, LGR4]
GO:0006448;regulation of translational elongation;8.0;0.7090535922965819;0.729526796148291;9.205667401672088;215.8173094633638;6.8867018697843045;0.007223211124770292;0.7271862538851576;[GRM5]
GO:0002523;leukocyte migration involved in inflammatory response;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;29.137022145890857;7.379178354882098;9.751899096054872E-4;0.7004918368257019;[FFAR2, CCR6, SELE, ELANE, S100A8, JAM3]
GO:0007416;synapse assembly;4.0;0.8436909121759173;0.6718454560879586;9.117698628726131;35.85243951974866;5.500407508664414;0.0011999488856252476;0.5312910957882058;[NLGN1, PCDHB14, CDH1, PCDHB16, PCDHB4]
GO:0099553;trans-synaptic signaling by endocannabinoid, modulating synaptic transmission;9.0;1.0;0.896240625180289;9.628524252492122;101.34340859682928;8.67846133901236;0.0033918726825895485;0.8400575416471059;[GRM5, CNR1]
GO:2000404;regulation of T cell migration;9.0;0.6954798709641801;0.743980560662379;9.168991923113682;54.41624510224751;6.250713103064308;0.0018212627521311273;0.7159023839588838;[CCR6]
GO:0030539;male genitalia development;5.0;1.0;0.7902410118609202;9.628524252492122;66.31594138202881;6.832634648514029;0.002219534877584045;0.639662265535933;[LHCGR, DHCR24, LGR4]
GO:0002407;dendritic cell chemotaxis;7.0;0.8653626801206646;0.7836007053175329;9.485423408851448;93.27947089202779;6.8867018697843045;0.0031219799446826077;0.7031056191423581;[CXCR1, CXCR2, CXCR4, CCR6]
GO:0061290;canonical Wnt signaling pathway involved in metanephric kidney development;9.0;0.9326813400603323;0.8625812952104552;9.567899630675686;106.74416304630388;9.083926447120524;0.0035726310736500203;0.8607930461318132;[LGR4]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, MEF2C, FCRL3, MSH6, BST1, BCL6]
GO:0033004;negative regulation of mast cell activation;7.0;0.8653626801206646;0.7836007053175329;9.5544162803384;126.92306413003195;7.379178354882098;0.00424800073309046;0.728290889492758;[CNR1, IL13RA2]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[EDNRB, C3AR1, IL1R1, IL1R2, BTK, PLA2G7, CD19, ELANE, LYN, BST1, FFAR2, TLR10, TLR7, PTGS2, IGKC, NLRP12, ZYX, CDH5, IGHG1, GHSR, S100A8, C5AR1, IGLV1-44, NLRP3, SELE, BCL6, IGKV3-20, TNFAIP6, CR2, CR1, CNR1, FCGR2B]
GO:0010700;negative regulation of norepinephrine secretion;9.0;1.0;0.896240625180289;9.628524252492122;256.762846099889;7.697632086000634;0.00859362138740423;0.7898978880348613;[GHSR]
GO:0031622;positive regulation of fever generation;9.0;0.8436909121759173;0.8180860812682478;9.454170865347344;276.00155245721845;7.8311634786251565;0.009237523575472428;0.7967266896635242;[CNR1, PTGS2]
GO:0051932;synaptic transmission, GABAergic;8.0;1.0;0.875;9.628524252492122;25.73829654599903;7.138016298065211;8.61437622431563E-4;0.7400384854347593;[GABRE]
GO:0031620;regulation of fever generation;8.0;0.7671156992804218;0.7585578496402109;9.168991923113682;57.99935624912111;7.697632086000634;0.0019411862576263126;0.7686572628545723;[EDNRB, CNR1, PTGS2]
GO:1903142;positive regulation of establishment of endothelial barrier;9.0;1.0;0.896240625180289;9.628524252492122;507.13258908748406;8.16763571524637;0.016973271367059242;0.8139338954918922;[CDH5]
GO:0007193;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.117698628726131;28.36322711391944;5.334422371190153;9.492916862557204E-4;0.6478026081386739;[GABBR1, HTR1E, NPY1R, FPR2, GNAI1, GNAI2, GRM5, ADCY9, RGS1, HRH4, FLNA]
GO:0007194;negative regulation of adenylate cyclase activity;12.0;0.8933024483968273;0.8947715367885583;9.589303539338841;6285.124034700197;6.481236761676141;0.21035744519701882;0.7795710619905949;[P2RY13, GABBR1, EDNRB, HRH4, GNAI2]
GO:0043408;regulation of MAPK cascade;9.0;0.6039883530135606;0.6982348016870694;8.647694999480395;157.04088149872794;3.1840290935380327;0.005256016976144841;0.5590720210963193;[, AKT1, PROK2, ATF3, FPR1, FPR2, IQGAP3, PDGFC, ELANE, LYN, NOX4, EZH2, DUSP2, DUSP1, FCRL3, DUSP6, PKN1, CTGF, MAP2K2, FOXO1, LRRK2, FCGR2B, PPP2R1A, EPHA3, CD24, PTPRR, MAP4K1, CEACAM1, BANK1, CXCR4, GNAI2, NLRP12, HGS, C5AR1, HRH4, TGFB1, INHBA, GH1, NUP62, CHI3L1, CD4]
GO:0007197;adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway;9.0;0.9326813400603323;0.8625812952104552;9.5544162803384;81.68848396009673;7.8311634786251565;0.0027340400432818626;0.7967266896635242;[HRH4]
GO:0014043;negative regulation of neuron maturation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;593.7949329038761;9.083926447120524;0.019873782023548055;0.8607930461318132;[EDNRB]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[MEF2C, SPINT1, BTK, SFN, LYN, BCL11B, CDC6, NOX4, CDKN1A, TNFRSF13B, PRL, PTPRK, BRCA2, DUSP1, ARG1, PAWR, CEACAM1, PTGS2, CDKN2C, PKN1, CDH5, DACH1, TSC2, HGS, NACC2, IGFBP7, TGFB1, HMGA1, DHCR24, INHBA, BCL6, OGN, CXCL1, NUP62, E2F7, CD9, FCGR2B]
GO:0007196;adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;85.0206884702681;7.57984905034425;0.002845565929447937;0.7838744581139225;[GRM5]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, MYB, AKT1, PROK2, MEF2C, CLDN7, ATF3, HHLA2, IQGAP3, PDGFC, ELANE, LYN, CDC6, CDKN1A, ARG1, FCRL3, MMP12, HBEGF, PTAFR, PTGS2, EPCAM, FLNA, LRG1, CTGF, FGF5, CDH3, MSH6, BLM, CORO1A, NACC2, BCL6, KLF5, TCL1A, EDNRB, SKP2, ICOSLG, RUNX2, BTC, EGR1, EGR3, PTK2, BST1, CD24, PRL, CD3E, RHOG, CEACAM6, GNAI2, CXCR2, GHSR, CCNE1, PRTN3, C5AR1, LTBP3, TGFB1, NR4A1, HMGB2, LAMC2, GLP2R, MMP9, LTF, MEIS2, TSHR, CD4]
GO:1905564;positive regulation of vascular endothelial cell proliferation;8.0;1.0;0.875;9.628524252492122;108.29290547333461;7.138016298065211;0.0036244660889050463;0.7400384854347593;[GHSR]
GO:0042311;vasodilation;8.0;0.7866048967936545;0.7683024483968273;9.148951172230236;40.37281764308888;6.599019797332524;0.0013512418733372556;0.712474179321389;[EDNRB]
GO:0040018;positive regulation of multicellular organism growth;6.0;1.0;0.8231203125901445;9.628524252492122;145.45792876686207;6.280566066213989;0.004868345972189967;0.6443087532925187;[GHSR, GH1]
GO:0019064;fusion of virus membrane with host plasma membrane;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;56.73089801191601;7.8311634786251565;0.0018987321019653565;0.7514054297404357;[CD4, CXCR4]
GO:0070588;calcium ion transmembrane transport;9.0;0.7140352122741334;0.7532582313173557;9.078477915572849;116.6808485568922;4.562137870071484;0.003905202995253044;0.629548568016852;[DENND5B, ATP2A3, SLC8A1, CACNA2D3, SLC24A1, SLC24A4]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[AKT1, MEF2C, RUNX2, FIGNL1, ALPL, LGR4]
GO:0050859;negative regulation of B cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;309.61561130321576;7.9853141584524145;0.010362555874359037;0.7833693374183408;[FCRL3]
GO:0038128;ERBB2 signaling pathway;9.0;0.8653626801206646;0.8289219652406215;9.36615998802463;32.38857880465376;6.343086423195323;0.0010840165847632744;0.7206263598461826;[PTPRR, GAB1, BTC, HBEGF]
GO:0032269;negative regulation of cellular protein metabolic process;7.0;0.4739867211454891;0.587912725829945;7.449991808168055;289.3917989888356;2.854429736204582;0.009685683076446155;0.4968950347112605;[PID1, AKT1, SPINT1, ATF3, PRKAR2B, SFN, LYN, PKIG, CDKN1A, LRRC4, DUSP2, DUSP1, PAX5, DUSP6, ENG, SERPINB10, PTGS2, CDKN2C, NR1H2, PKN1, FOXO1, TNFRSF10C, DHCR24, CNOT3, LRRK2, HHEX, CR1, NLRC4, EDNRB, PPP2R1A, FBXO5, IL1R2, POR, SLPI, PTPRR, CEACAM1, BANK1, GNAI2, NLRP12, TSC2, TGFB1, NUP62, MMP9, LTF]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[CD3G, CD3E, GRAP2, ICOSLG, BTK, HHLA2, HLA-DQA1, TRAT1, BMX, CD4, HLA-DRA, LAT]
GO:1904000;positive regulation of eating behavior;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.88607859474252;8.390779266560578;0.0016696421560100983;0.7522251544931926;[GHSR]
GO:0046928;regulation of neurotransmitter secretion;7.0;0.6493065804076676;0.6755726554610344;8.817594036275793;103.1091377978561;5.71663061713405;0.0034509700498948056;0.6432681208679463;[NLGN1, MCTP1, LRRK2, MEF2C, CHRNB4]
GO:0086100;endothelin receptor signaling pathway;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;26.976932752798508;9.083926447120524;9.028936615729279E-4;0.7876727335416686;[EDNRB]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[HHLA2, CD3E, GRAP2, BTLA, AKT1, ICOSLG, LYN, CD24]
GO:0060416;response to growth hormone;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;7.138016298065211;0.0024778305216419678;0.7159578506919597;[GHSR, AKT1]
GO:0035094;response to nicotine;4.0;0.9326813400603323;0.7163406700301662;9.446202695698167;26.17342148764107;5.926926025970411;8.760008626412986E-4;0.5531032725983739;[CHRNB4, CNR1]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[, PROK2, EPHA3, FPR1, FPR2, IQGAP3, PDGFC, ELANE, NOX4, CD24, EZH2, MAP4K1, FCRL3, DUSP6, BANK1, CXCR4, GNAI2, PKN1, CTGF, MAP2K2, C5AR1, TGFB1, GH1, LRRK2, CHI3L1, CD4, FCGR2B]
GO:0002503;peptide antigen assembly with MHC class II protein complex;7.0;1.0;0.8509193652572005;9.628524252492122;45.61567929762514;8.67846133901236;0.0015267157346454312;0.7947362817240173;[HLA-DMA, HLA-DRA]
GO:0002866;positive regulation of acute inflammatory response to antigenic stimulus;9.0;0.7866048967936545;0.7895430735771163;9.423729839846109;536.1761589628609;7.8311634786251565;0.017945333513272207;0.7967266896635242;[CNR1, BTK]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[EDNRB, GHSR, MEF2C, CD180, SLPI, S100A8, ABCB4, C5AR1, MGST1, LY96, CSF2RB, STAP1, NLRP3, ELANE, DEFA4, TNFRSF10C, DEFA1, SELE, ALPL, HMGB2, CXCL1, CXCL2, CTSG, ARG1, CEBPE, PTGS2, CNR1, NR1H2]
GO:1990839;response to endothelin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;9.083926447120524;0.0024778305216419678;0.8154717862087246;[EDNRB]
GO:0035645;enteric smooth muscle cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;23.368810875791638;9.777073627680469;7.821330694483778E-4;0.8231203125901445;[EDNRB]
GO:0071548;response to dexamethasone;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;124.89021324540595;6.015873511986907;0.004179963043429046;0.6826520511697386;[PCNA, ABCB4, PTAFR, FOXO1, GHSR, TGFB1, ARG1]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[SLA2, FGF5, GRAP2, MAP2K2, BTC, MELK, BTK, EPHA3, BLK, CSF2RB, LYN, BMX, PTK2, HBEGF, WEE1]
GO:0032099;negative regulation of appetite;9.0;0.9326813400603323;0.8625812952104552;9.567899630675686;112.2830746356052;7.292166977892469;0.0037580134598471393;0.769162383550154;[GHSR]
GO:1902476;chloride transmembrane transport;8.0;1.0;0.875;9.628524252492122;110.5175749436453;5.311165509025885;0.0036989237740038075;0.6466132511260384;[GABRE, CLCA4, CLDN4, SLC26A8, CLDN17, SLC26A3]
GO:1902358;sulfate transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;123.29733532969695;7.069023426578259;0.0041266508530873195;0.7365101867784198;[SLC26A8, SLC26A3]
GO:0007214;gamma-aminobutyric acid signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.976932752798508;6.558197802812269;9.028936615729279E-4;0.6585068532133508;[GABBR1, GABRE, GNAI2]
GO:0009755;hormone-mediated signaling pathway;5.0;0.6519675769143192;0.6162248003180799;7.98629651723503;23.17027026302992;4.61801832846594;7.75488093814194E-4;0.5264066839384828;[NR3C2, NUP62, GHSR, LHCGR, ACSL1, CCNE1, PADI2, NR1H2, DEFA1, TSHR, NR4A2, NR4A1, RAN, LGR4]
GO:0048714;positive regulation of oligodendrocyte differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;471.693664190925;6.943860283624253;0.01578716244373315;0.7703503496879909;[CXCR4]
GO:0071294;cellular response to zinc ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;6.641579411751319;0.0026274528238337297;0.6627709925721352;[HVCN1]
GO:0043031;negative regulation of macrophage activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.92306413003195;7.57984905034425;0.00424800073309046;0.738553198190834;[BPI, FCGR2B, CD200]
GO:0048169;regulation of long-term neuronal synaptic plasticity;9.0;0.8933024483968273;0.8428918493787028;9.461470167828956;42.75619717690252;6.481236761676141;0.0014310114414316764;0.7276913745807394;[GRM5]
GO:0050911;detection of chemical stimulus involved in sensory perception of smell;5.0;1.0;0.7902410118609202;9.628524252492122;23.389107696328047;3.713288418992861;7.828123857657788E-4;0.48013875429378605;[OR1G1, OR11A1]
GO:0060291;long-term synaptic potentiation;8.0;1.0;0.875;9.628524252492122;145.7697243391103;5.948432231191374;0.004878781489395318;0.6792031009335148;[SLC24A1, NLGN1, PLK2, TNR]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[CYFIP1, CPNE5, EPHA3, LYN, EZH2, NLGN1, CNR1]
GO:0060292;long term synaptic depression;8.0;1.0;0.875;9.628524252492122;145.80791725818347;7.004484905440688;0.004880059772025301;0.7332096838060964;[SLC24A1, PLK2]
GO:1905184;positive regulation of protein serine/threonine phosphatase activity;11.0;1.0;0.9324289523296623;9.628524252492122;1090.3691173458615;9.777073627680469;0.036493673089069714;0.9324289523296623;[FCRL3]
GO:0036321;ghrelin secretion;9.0;1.0;0.896240625180289;9.628524252492122;118.18185027952968;9.777073627680469;0.0039554401720958724;0.896240625180289;[GHSR]
GO:0045577;regulation of B cell differentiation;8.0;0.7369933605727446;0.7434966802863723;9.223059144383958;130.3775146173893;6.518977089658987;0.004363618082098712;0.7083807915285978;[FCRL3, INHBA, BTK]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[LRRK2, RUVBL1, JUP, SULF2, LGR4]
GO:0043278;response to morphine;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;93.3430750065417;6.280566066213989;0.0031241087171554015;0.6721078059595746;[ABCB4, TACR3, CNR1]
GO:0045580;regulation of T cell differentiation;8.0;0.5976175254657065;0.6738087627328533;8.663443356448536;131.165971977755;4.909539177224887;0.004390007040384596;0.626074061840201;[CD83, IFNA2, MYB, HLA-DOA, CR1, CLPTM1, NLRP3, TGFB1, EGR3, CD2, VNN1, BCL6, CAMK4]
GO:0098664;G-protein coupled serotonin receptor signaling pathway;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;51.24581530449654;6.599019797332524;0.0017151513200019748;0.6605944919115335;[HTR1E]
GO:0051454;intracellular pH elevation;11.0;0.8436909121759173;0.8542744084176208;9.481920778300246;181.15151768737684;7.9853141584524145;0.006062978271215114;0.8407982897480031;[SLC26A3]
GO:0048290;isotype switching to IgA isotypes;13.0;1.0;0.9625549647676366;9.628524252492122;268.78471588944643;9.777073627680469;0.008995982550280335;0.9625549647676366;[CCR6]
GO:0050920;regulation of chemotaxis;5.0;0.536669693073893;0.5585758583978668;7.309409857546866;25.007338360703717;4.4540636485420615;8.369731097893864E-4;0.5180220339825032;[C3AR1, PADI2, C5AR1, FPR2, PLA2G7, STAP1, ELANE, LYN, TGFB1, AZU1, BST1, GPR18, CXCL1, CXCL2, CCR6, CXCR4, CXCR2, JAM3]
GO:0033602;negative regulation of dopamine secretion;9.0;1.0;0.896240625180289;9.628524252492122;383.5961800611833;8.67846133901236;0.012838618932498951;0.8400575416471059;[CNR1]
GO:0035589;G-protein coupled purinergic nucleotide receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;82.06132384088221;7.069023426578259;0.0027465186585576445;0.7365101867784198;[P2RY13, P2RY14, PTAFR]
GO:0035584;calcium-mediated signaling using intracellular calcium source;8.0;1.0;0.875;9.628524252492122;30.117246255164275;6.781341354126479;0.0010079971283984438;0.7217981122146513;[GRM5, AZU1]
GO:0120058;positive regulation of small intestinal transit;7.0;1.0;0.8509193652572005;9.628524252492122;64.83277238479364;9.083926447120524;0.002169894546012021;0.8154717862087246;[GHSR]
GO:0038171;cannabinoid signaling pathway;6.0;0.8653626801206646;0.7558016526504768;9.4949928598676;26.976932752798508;8.16763571524637;9.028936615729279E-4;0.7408135829017477;[CNR1]
GO:0046676;negative regulation of insulin secretion;10.0;0.9326813400603323;0.8815816818910864;9.59953671561887;1038.4904202001212;6.193554689224359;0.03475733978339799;0.731979686697602;[GHSR]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[STMN1, IFNA14, IFNA16, RNASE6, RNASE2, IFNA10, NLRP3, IFNA21, HMGA1, AZU1, DEFA1, IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, MMP12, TLR8, TLR7, UNC93B1, CXCR4, SAMHD1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[EHMT2, SLA2, MYB, MEF2C, ATF3, ELANE, PKIG, EZH2, PAWR, PAX5, AES, MMP12, NR1H2, DACH1, TLE4, FOXO1, NACC2, WFS1, BCL6, CIITA, HHEX, RFC1, RBBP8, E2F7, KLF8, KLF5, ZNF608, EDNRB, PCBP3, EGR1, BCL11A, XPO1, CCNE1, TGFB1, CBX4, NR4A2, MXD1, FBP1, MEIS2]
GO:0032869;cellular response to insulin stimulus;8.0;1.0;0.875;9.628524252492122;462.69925393661634;5.334422371190153;0.015486127626965131;0.6478026081386739;[CYFIP1, AKT1, GHSR, CEACAM1, FOXO1]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[CLDN3, CLDN7, S100A8, CNR1, GSN]
GO:0038044;transforming growth factor-beta secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;9.083926447120524;0.004587596526932657;0.8797934328124444;[ITGB6]
GO:0034122;negative regulation of toll-like receptor signaling pathway;8.0;0.7140352122741334;0.7320176061370667;9.0094850440859;260.8137256220838;6.166155715036245;0.00872920067945721;0.6903374900225189;[LYN, LY96, LGR4]
GO:0007202;activation of phospholipase C activity;9.0;1.0;0.896240625180289;9.628524252492122;83.73920694944017;6.444869117505266;0.0028026758962043192;0.7258315315665724;[C5AR1, SELE, RASGRP4]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[NUP107, SLA2, SPIB, AKT1, ATF3, JAG1, JUP, PKIG, CHAF1B, MMP12, PTAFR, ZNF467, ATAD2, PKN1, LGR4, GMNN, BLM, CIITA, HHEX, E2F5, E2F7, POU2AF1, FBXO5, BTK, EGR1, EGR2, EGR3, POLA1, PCNA, NR3C2, TCF4, MXD1, NUP133, FBP1, CD4, NUP85, NFE2, CDKN1A, ZNF367, EPCAM, NR1H2, TLE4, MAP2K2, BCL6, CCDC22, SLC26A3, RFC1, CEBPE, NLRC4, PPIL4, PPP2R1A, SIK1, IFNA2, PRL, XPO1, MLF2, NLRP3, CBX4, SLC40A1, DNM2, LTF, PID1, EHMT2, MEF2C, PADI2, EZH2, FLNA, RUVBL1, S100A8, MAZ, FOXO1, CCNH, TMPO, PCBP3, PTPRK, BRCA2, NLRP12, CCNE1, HMGA1, INHBA, HMGB2, ARHGEF10L, AFF3, NUP62, PSRC1, CREB5, NUP35, RAN, EHF, HOXA9, MYB, ELANE, CDC6, BRD2, ANXA3, PAWR, PAX5, AES, ENG, GTF2H1, DACH1, CDH1, NACC2, WFS1, CNOT3, MAFF, RBBP8, KLF8, KLF5, ZNF608, EDNRB, CHEK1, EBF1, RUNX2, PFN1, BEX1, SP140, BCL11B, BCL11A, RHOG, SGK1, CAMK4, ARID4A, BASP1, TGFB1, NR4A2, NR4A1, CKAP2, MEIS2]
GO:0001580;detection of chemical stimulus involved in sensory perception of bitter taste;6.0;1.0;0.8231203125901445;9.628524252492122;24.998545608763582;6.063501560976162;8.36678824294913E-4;0.6332080644001243;[TAS2R7, TAS2R10]
GO:0045597;positive regulation of cell differentiation;5.0;0.4493394816318884;0.5149107526768645;6.573475401781711;82.53300662006848;2.970244267288293;0.0027623054566900678;0.44213944182052767;[CYFIP1, MYB, AKT1, MEF2C, SPINT1, SFN, LYN, JAG1, EZH2, ENG, PTGS2, FLNA, CTGF, CDH5, OLFM4, TACSTD2, BCL6, ADAMTS20, NLGN1, KLF5, CPNE5, RUNX2, BTC, POR, BTK, EPHA3, EGR3, VNN1, CD24, CEACAM1, CXCR4, CD83, LTBP3, NLRP3, TGFB1, INHBA, TCF4, DOCK5, HMGB2, DNM2, LTF, CNR1, CD4, ACIN1]
GO:0007200;phospholipase C-activating G-protein coupled receptor signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.976932752798508;5.288437257948329;9.028936615729279E-4;0.5935712398991049;[LHCGR, C5AR1, FPR1, FPR2, GPR84, GRM5, EDNRB, CXCR2, C3AR1]
GO:0072282;metanephric nephron tubule morphogenesis;8.0;0.8933024483968273;0.8216512241984136;9.461470167828956;83.31319846882946;8.390779266560578;0.0027884177757410197;0.8041048419030481;[LGR4]
GO:0007206;phospholipase C-activating G-protein coupled glutamate receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;83.92207618159998;9.083926447120524;0.0028087963648330836;0.839552420951524;[GRM5]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[SLC8A1, EDNRB, C3AR1, PROK2, C5AR1, FPR1, FPR2, CD19, HRH4, CD24, GPR18, CCR9, CCR6, CD52, CXCR5, CXCR4, CXCR1, CXCR2, GPR6, P2RX5, CD4]
GO:1902938;regulation of intracellular calcium activated chloride channel activity;9.0;0.8933024483968273;0.8428918493787028;9.517298617381897;199.08006120767874;8.67846133901236;0.006663030488198;0.8400575416471059;[GRM5]
GO:0030318;melanocyte differentiation;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;22.857985252022832;6.8867018697843045;7.650361955340501E-4;0.6424272657460779;[MEF2C, EDNRB]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[AKT1, PROK2, MEF2C, CLDN7, FIGNL1, SFN, BARD1, PLK2, AZU1, CDKN1A, CHL1, DUSP1, ANXA5, PTGS2, UNG, FLNA, CLEC5A, MSH2, BLM, CORO1A, FOXO1, WFS1, TNFRSF10C, DHCR24, BCL6, LRRK2, ADAMTS20, LRP1, NLRC4, LGALS3, TCL1A, EDNRB, BTC, POR, EPHA3, EGR3, BCL11B, PTK2, VNN1, CEACAM6, GNAI2, CXCR2, GHSR, C5AR1, CBX4, NR4A2, HMGB2, SLC40A1, NUP62, MMP9, LTF]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CXCR5, CXCR4, CXCL1, CXCL2, CXCR1, CXCR2, CCR9, CCR6]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, MEF2C, ATF3, SFN, BARD1, LYN, NOX4, DUSP1, PAWR, DUSP6, AES, PTGS2, FGD4, GSN, BIK, G0S2, CTGF, MELK, MAL, S100A8, FOXO1, NACC2, BCL6, NLRC4, PPP2R1A, SIK1, ITM2C, CXCR2, SORT1, PPP1CA, NLRP12, NLRP3, TGFB1, INHBA, UBE2M, MMP9, DNM2, CNR1]
GO:0016266;O-glycan processing;9.0;0.7866048967936545;0.7895430735771163;9.277126365654233;178.64096908048714;5.666199763507158;0.0059789524686895724;0.6860103445912811;[ST6GALNAC2, GXYLT2, MUC15, GALNT6, B3GNT5]
GO:0019532;oxalate transport;9.0;0.9326813400603323;0.8625812952104552;9.541512875502493;53.14108600855652;7.292166977892469;0.0017785843248339678;0.769162383550154;[SLC26A8, SLC26A3]
